1-8 of 8
Keywords: Parkinsons disease
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Biochem J (2023) 480 (11): 815–833.
Published: 12 June 2023
.... LRRK2 mutations are linked to Parkinson's Disease (PD). Recent structures of LRRK2 RCKW and a full-length inactive LRRK2 (fl-LRRK2 INACT ) monomer revealed that the kinase domain drives LRRK2 activation. The LRR domain and also an ordered LRR–COR linker, wrap around the C-lobe of the kinase domain...
Includes: Supplementary data
Articles
Biochem J (2021) 478 (23): 4099–4118.
Published: 06 December 2021
...Eliona Tsefou; Alison S. Walker; Emily H. Clark; Amy R. Hicks; Christin Luft; Kunitoshi Takeda; Toru Watanabe; Bianca Ramazio; James M. Staddon; Thomas Briston; Robin Ketteler Mitochondrial dysfunction is implicated in Parkinson disease (PD). Mutations in Parkin, an E3 ubiquitin ligase, can cause...
Includes: Supplementary data
Articles
Biochem J (2021) 478 (19): 3555–3573.
Published: 06 October 2021
...Anna Tasegian; Francois Singh; Ian G. Ganley; Alastair D. Reith; Dario R. Alessi Much effort has been devoted to the development of selective inhibitors of the LRRK2 as a potential treatment for LRRK2 driven Parkinson's disease. In this study, we first compare the properties of Type I (GSK3357679A...
Includes: Supplementary data
Articles
Articles
Biochem J (2020) 477 (22): 4397–4423.
Published: 27 November 2020
...Alexia F. Kalogeropulou; Jordana B. Freemantle; Pawel Lis; Edmundo G. Vides; Nicole K. Polinski; Dario R. Alessi Mutations that enhance LRRK2 protein kinase activity cause inherited Parkinson's disease. LRRK2 phosphorylates a group of Rab GTPase proteins, including Rab10 and Rab12, within...
Includes: Supplementary data
Articles
Biochem J (2000) 349 (1): 289–297.
Published: 26 June 2000
... whether the iron deposition in the pathological area of the Parkinsonian monkey brain was due to an increased iron uptake through the Nramp2 iron transporter. Subsequently, the patho- physiological mechanisms that lead to Parkinson disease can be investigated. This work was supported by a grant, RP3950376...
Articles
Biochem J (2000) 346 (3): 577–581.
Published: 07 March 2000
...Robert A. FURLONG; Yolanda NARAIN; Julia RANKIN; Andreas WYTTENBACH; David C. RUBINSZTEIN Protein aggregates are a neuropathological feature of Huntington's disease and Parkinson's disease. Mutant huntingtin exon 1 with 72 CAG repeats fused to enhanced green fluorescent protein (EGFP) forms...
Articles
Biochem J (1999) 340 (3): 821–828.
Published: 08 June 1999
...Seung R. PAIK; Hyun-Ju SHIN; Ju-Hyun LEE; Chung-Soon CHANG; Jongsun KIM α-Synuclein is a component of the abnormal protein depositions in senile plaques and Lewy bodies of Alzheimer's disease (AD) and Parkinson's disease respectively. The protein was suggested to provide a possible nucleation...